Elevance Health, Inc. (ELV) stock
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3011% below fair value
$433.93−12.35 (-2.77%)
Close on Nov 17, 2026Market cap $93.75BP/E 18.5Yield –
Elevance Health total assets
Total assets on the balance sheet at the end of each period.
Elevance Health's total assets was $127.80B at Sep 30, 2026. For fiscal 2025 it was $121.49B, up 3.9% from the year before. Over ten years it grew 7.0% a year on average. The highest annual figure on record is $121.49B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $121.49B | +3.9% |
| FY2024 | Dec 31, 2024 | $116.89B | +7.3% |
| FY2023 | Dec 31, 2023 | $108.93B | +6.0% |
| FY2022 | Dec 31, 2022 | $102.76B | +5.4% |
| FY2021 | Dec 31, 2021 | $97.46B | +12.5% |
| FY2020 | Dec 31, 2020 | $86.62B | +11.8% |
| FY2019 | Dec 31, 2019 | $77.45B | +8.2% |
| FY2018 | Dec 31, 2018 | $71.57B | +1.5% |
| FY2017 | Dec 31, 2017 | $70.54B | +8.4% |
| FY2016 | Dec 31, 2016 | $65.08B | +5.5% |
| FY2015 | Dec 31, 2015 | $61.72B | +0.1% |
| FY2014 | Dec 31, 2014 | $61.68B | +3.5% |
| FY2013 | Dec 31, 2013 | $59.57B | +1.1% |
| FY2012 | Dec 31, 2012 | $58.96B | +13.0% |
| FY2011 | Dec 31, 2011 | $52.16B | +4.0% |
| FY2010 | Dec 31, 2010 | $50.17B | -3.8% |
| FY2009 | Dec 31, 2009 | $52.13B | +7.7% |
| FY2008 | Dec 31, 2008 | $48.40B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $127.80B | +4.1% |
| Q2 FY2026 | Jun 30, 2026 | $126.44B | +3.7% |
| Q1 FY2026 | Mar 31, 2026 | $125.83B | +5.1% |
| Q4 FY2025 | Dec 31, 2025 | $121.49B | +3.9% |
| Q3 FY2025 | Sep 30, 2025 | $122.75B | +5.3% |
| Q2 FY2025 | Jun 30, 2025 | $121.94B | +7.9% |
| Q1 FY2025 | Mar 31, 2025 | $119.72B | +7.0% |
| Q4 FY2024 | Dec 31, 2024 | $116.89B | +7.3% |
| Q3 FY2024 | Sep 30, 2024 | $116.53B | +5.5% |
| Q2 FY2024 | Jun 30, 2024 | $112.99B | +3.5% |
| Q1 FY2024 | Mar 31, 2024 | $111.89B | +2.6% |
| Q4 FY2023 | Dec 31, 2023 | $108.93B | +6.0% |
| Q3 FY2023 | Sep 30, 2023 | $110.48B | +7.2% |
| Q2 FY2023 | Jun 30, 2023 | $109.17B | +8.2% |
| Q1 FY2023 | Mar 31, 2023 | $109.04B | +8.5% |
| Q4 FY2022 | Dec 31, 2022 | $102.76B | +5.4% |
| Q3 FY2022 | Sep 30, 2022 | $103.03B | +5.1% |
| Q2 FY2022 | Jun 30, 2022 | $100.88B | +5.0% |
| Q1 FY2022 | Mar 31, 2022 | $100.49B | +5.0% |
| Q4 FY2021 | Dec 31, 2021 | $97.46B | +12.5% |
| Q3 FY2021 | Sep 30, 2021 | $98.06B | +13.3% |
| Q2 FY2021 | Jun 30, 2021 | $96.10B | +9.2% |
| Q1 FY2021 | Mar 31, 2021 | $95.68B | +16.1% |
| Q4 FY2020 | Dec 31, 2020 | $86.62B | +11.8% |
| Q3 FY2020 | Sep 30, 2020 | $86.57B | +11.3% |
| Q2 FY2020 | Jun 30, 2020 | $87.98B | +16.0% |
| Q1 FY2020 | Mar 31, 2020 | $82.40B | +10.6% |
| Q4 FY2019 | Dec 31, 2019 | $77.45B | +8.2% |
| Q3 FY2019 | Sep 30, 2019 | $77.81B | +4.5% |
| Q2 FY2019 | Jun 30, 2019 | $75.85B | +2.0% |
| Q1 FY2019 | Mar 31, 2019 | $74.52B | +1.7% |
| Q4 FY2018 | Dec 31, 2018 | $71.57B | +1.5% |
| Q3 FY2018 | Sep 30, 2018 | $74.45B | +9.0% |
| Q2 FY2018 | Jun 30, 2018 | $74.37B | +9.0% |
| Q1 FY2018 | Mar 31, 2018 | $73.30B | +6.3% |
| Q4 FY2017 | Dec 31, 2017 | $70.54B | +8.4% |
| Q3 FY2017 | Sep 30, 2017 | $68.31B | – |
| Q2 FY2017 | Jun 30, 2017 | $68.24B | – |
| Q1 FY2017 | Mar 31, 2017 | $68.94B | – |
| Q4 FY2016 | Dec 31, 2016 | $65.08B | – |
See a number that looks wrong?